Welcome to our dedicated page for U S Physical Therapy news (Ticker: USPH), a resource for investors and traders seeking the latest updates and insights on U S Physical Therapy stock.
U.S. Physical Therapy reports recurring developments tied to its national outpatient physical therapy clinic network and industrial injury prevention services business. Company news commonly covers physical therapy revenue, mature-clinic activity, gross profit, reimbursement-sensitive care categories, and services for orthopedic conditions, sports injuries, neurological injuries, post-operative care, preventative care, and injured-worker rehabilitation.
Updates also include acquisitions of clinic practices and industrial injury prevention businesses, hospital and regional care alliances, investor presentations, dividends, share repurchases, and credit facility changes. Its industrial injury prevention services include onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments for client workforces.
U.S. Physical Therapy, Inc. (USPH) reported Q2 2022 results, showing Operating Results per diluted share at $0.90, slightly down from $0.96 in 2021. Net income fell to $11.2 million from $12.4 million. Total revenue reached $140.7 million, up 10.8% year-over-year, driven by a 5.7% rise in total patient visits. However, total operating costs rose to 78.1% of revenue, impacting gross profit, which decreased by 10.2% to $30.8 million. The company announced a $325 million credit facility to support growth and a quarterly dividend of $0.41 per share. Adjusted EBITDA for 2022 is projected at $73.5 to $75.4 million.
U.S. Physical Therapy, Inc. (NYSE: USPH) will release its financial results for the second quarter and six months ended June 30, 2022, on Thursday, August 4, 2022, before market opening. Management will host a conference call on the same day at 10:30 am Eastern to discuss the results. The conference call can be accessed by dialing (800) 459-5346 or (203) 518-9544, using Conference ID: USPHQ22022. U.S. Physical Therapy operates 607 outpatient clinics across 38 states, providing orthopedic care, rehabilitation, and industrial injury prevention services.
U.S. Physical Therapy, Inc. (NYSE: USPH) announced the closing of a $325 million credit facility, which includes a $150 million term loan and a $175 million revolver, up from the initial $300 million. The facility aims to enhance liquidity and support growth. An interest rate swap was also executed to manage interest rate risk, locking in a rate of 2.815% on $150 million of debt. This strategic move reflects the company's commitment to maintaining a robust balance sheet amid rising interest rates.
U.S. Physical Therapy, Inc. (NYSE: USPH) announced that CFO Carey Hendrickson will participate in the East Coast IDEAS Virtual Conference on June 22, 2022. The presentation will provide an overview of the Company, which operates 608 outpatient physical therapy clinics across 38 states. U.S. Physical Therapy specializes in preventative and post-operative care for orthopedic and sports-related injuries, as well as rehabilitation for injured workers. More information can be found at www.usph.com.
Nutex Health has appointed Jon Bates as the new Chief Financial Officer, effective June 30, 2022. Bates, with significant experience in finance, has previously served as VP of Accounting at U.S. Physical Therapy, managing over $500 million in annual revenues and 600+ locations. His expertise spans strategic planning, risk assessment, and internal auditing. Former CFO Michael Bowen plans to retire but will assist in the transition for the next year. The leadership change aims to enhance Nutex Health’s operational strength as it pursues growth initiatives.
U.S. Physical Therapy, Inc. (NYSE: USPH) announced that CEO Chris Reading and CFO Carey Hendrickson will present at the Jefferies Healthcare Conference on June 8, 2022. The presentation aims to provide an overview of the company, which operates 608 clinics across 38 states, offering treatment for orthopedic and sports injuries, as well as rehabilitation services. The company also manages 35 facilities for third parties and provides industrial injury prevention services. For more details, visit www.usph.com.
U.S. Physical Therapy (USPH) reported strong Q1 2022 results with net income of $8.8 million, up from $8.2 million year-over-year. Earnings per diluted share increased to $0.67 from $0.21. Total revenue reached $131.7 million, a 17.2% rise, while adjusted EBITDA grew 14.2% to $17.9 million. Patient visits increased by 12.2%, totaling over 1 million. The company declared a quarterly dividend of $0.41 per share payable on June 14, 2022. A significant acquisition of a six-clinic practice was also completed, enhancing growth prospects.
U.S. Physical Therapy, Inc. (NYSE: USPH) will release its financial results for Q1 ended March 31, 2022 on May 5, 2022, before market opening. A conference call will follow at 10:30 am Eastern to discuss the results. Interested participants can dial (877) 830-2598, and the Conference ID is USPHQ12022. U.S. Physical Therapy operates 601 outpatient clinics across 39 states, providing various services, including orthopedic and neurological rehabilitation.
U.S. Physical Therapy, Inc. (USPH) has announced the acquisition of a six-clinic physical therapy practice, Madden and Gilbert Physical Therapy, LLC, in South Central Pennsylvania. The Company acquired 70% of the equity for approximately $11.5 million, with the practice's founders retaining the remaining 30%. This practice generates over $7.5 million in annual revenue and handles around 71,000 patient visits annually. CEO Chris Reading emphasized the partnership's potential for market expansion and enhanced patient service.
U.S. Physical Therapy, Inc. (USPH) reported strong financial results for the fourth quarter and full year of 2021. Net income grew to $40.8 million for the year, a 15.9% increase compared to 2020. The company raised its dividend by 7.9% to $0.41 per share. Average patient visits per clinic reached a record 29.1 for the year. Despite challenges like Medicare rate reductions expected in 2022, management anticipates earnings between $3.25 and $3.35 per diluted share for 2022. Total revenue for Q4 was $129.8 million, up 10.5% year-over-year, with solid growth in net patient revenue and industrial injury prevention services.